Exavir Therapeutics
San Francisco · Founded 2020
About Exavir Therapeutics
Exavir Therapeutics is a preclinical stage biotechnology company dedicated to eliminating HIV and other viral infections with a broad modality-agnostic approach, beginning with long-acting antiviral therapeutics.
Company Facts
- Founded: 2020
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.0M
- Funding stage: Seed
- Last round: Grant (Aug 2023)
- Website: https://exavirtherapeutics.com/
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/exavir-therapeutics-115347 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.